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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
COVID-19: Reducing the risk of infection might increase the risk of intimate partner 
violence 
Gelder et al. | EClinical Medicine | 13 April 2020  
https://doi.org/10.1016/j.eclinm.2020.100348 
While quarantines are an effective measure of infection control, they can lead to significant social, 
economic and psychological consequences including increased risk of intimate partner violence 
(IPV). This paper highlights action needed to be taken to mitigate against increases in IPV. 
Risk and vulnerability related to disability and COVID-19 
Dean et al. | ARISE Consortium | 14 April 2020 | First blog of Twitter chat on Disability and 
COVID-19 
http://www.ariseconsortium.org/risks-and-vulnerability-related-to-disability-and-covid-19/ 
On 6 April, ARISE hosted a Twitter Chat on Disability and COVID-19 bringing together people with 
disabilities, disabled persons organisations, NGOs, and other experts from around the world. The 
chat was structured around seven questions with the aim of identifying people, organisations and 
networks with expertise in disability and COVID-19 and further resources; highlighting particular 
needs of people with disabilities and potential gaps in the COVID-19 messaging and response 
(with a focus on LMICs); and explore how people with disabilities are being included in the COVID-
19 response. The learnings from the Twitter Chat have been synthesised and organised into a 
series of five blogs with the first blog now published. 
Risks and vulnerabilities for people with disability in relation to COVID-19 are shaped by context 
and individual factors such as age, gender and impairment. Vulnerabilities can manifest in multiple 
ways from vulnerability to infection and to severe illness, to lack of access to services or de-
prioritisation and to social, political and economic effects of the pandemic. Disability may intersect 
with other axes of oppression e.g. gender. 
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Not Dying Alone – modern compassionate care in the COVID-19 pandemic 
Wakam et al. | NEJM | 14 April 2020 | Perspective 
https://www.nejm.org/doi/pdf/10.1056 
This Perspective based on experience from an ICU at a community hospital in Detroit, USA 
highlights the ethical and health care dilemma that the COVID-19 pandemic presents for all 
patients who are going to die when access of families, who are usually encouraged to be with their 
loved ones, is denied.  “The fear of dying alone is nearly universal”. A recent Perspective on 
Telemedicine for COVID-19 and guidance, whilst not evidence-based, regards difficult but 
necessary conversations related to COVID-19 and ways of maintaining physical distance and tries 
to capture caring not just for patients but also for their families and friends. National guidance would 
be beneficial and creative solutions connecting patients and their families harnessing the care and 
compassion of frontline health care workers may help.  
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period 
Kissler, S.M., et al. | Science | 14 April 2020 | Report 
https://doi.org/10.1126/science.abb5793 
Using a combination of viral, environmental and immunological factors which determine the 
dynamics of SARS-CoV-2, this modelling paper projects potential scenarios for SARS-CoV-2 
transmission under specific assumptions through and after the pandemic periods and identifies 
key data still needed to determine which scenarios are likely to happen. The model is then used to 
assess the duration and intensity of social distancing measures that might be needed to maintain 
control of SARS-CoV-2 in the coming months under both existing and expanded critical care 
capacities. Prolonged or intermittent social distancing may be necessary into 2022 to ensure 
critical care capacities are not exceeded unless critical care capacity is increased substantially, or 
a treatment or vaccine becomes available. Highly effective distancing could reduce SARS-CoV-2 
incidence sufficiently to switch to a strategy of contract tracing and quarantine. The model will have 
to be tailored to local conditions and updated as more accurate data become available. 
Longitudinal serological studies are urgently needed to determine the extent and duration of 
immunity to SARS-CoV-2. Surveillance of SARS-CoV-2 should be maintained, even in the event 
of apparent elimination, as a resurgence in contagion could be possible as late as 2024. 
Spread of SARS-CoV-2 in the Icelandic Population 
Gudbjartsson et al. | NEJM | 14 April 2020 | Article 
https://doi.org/10.1056/NEJMoa2006100 
This study targeted two groups for testing for SARS-CoV-2 infection to (1) persons living in Iceland 
who were at high risk for infection and (2) population screening through open invitation. The 
percentage of participants who tested positive in population screening remained stable (0.8%) from 
13 March to 1 April consistent with slow spread of SARS-CoV-2 through the Icelandic population 
and a beneficial effect of containment efforts. Young children and females were less likely to test 
positive for SARS-CoV-2 than adolescents and males. It is unknown whether this is from less 
exposure to the virus or from biologic resistance. 
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COVID-19: health literacy is an underestimated problem 
Paakkari, L. & Okan, O. |The Lancet Public Health | 14 April 2020 | Comment 
https://doi.org/10.1016/S2468-2667(20)30086-4 
The COVID-19 infodemic has highlighted the need for people to acquire, understand and apply 
health information, in the context of complex, contradictory and false information, and use this 
information in a sound and ethical manner to adapt their behaviour at pace i.e. be health literate. 
Solidarity and social responsibility should also be considered “within the toolbox of health literacy” 
and accounted for by not only the general population and decision makers but also by individuals 
who produce and share misleading and false information about SARS-CoV-2. 
SARS-CoV-2 molecular assay evaluation: results 
FIND | April 2020 | Independent evaluation of SARS-CoV-2 molecular assays 
https://www.finddx.org/covid-19/sarscov2-eval-molecular/molecular-eval-results/ 
The first independent SARS-CoV-2 molecular assay evaluation test results are now published. 
Online learning and events 
Emerging respiratory viruses, including COVID-19: methods for detection, prevention, 
response and control 
WHO | Free | 3 hours duration  
https://openwho.org/courses/introduction-to-ncov 
A general introduction to enable you to describe the fundamental principles of emerging 
respiratory viruses, including novel coronaviruses, and how to effectively respond to an outbreak. 
Intended for public health professionals, incident managers and personnel working for the UN, 
international organisations and NGOs. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 25 May 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
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Unfacilitated access to this course remains. An updated version of this course will though be run 
from 25 May 2020. On this course you will learn what is known about the outbreak of COVID-19 
(week 1); what the practical implications for responding to COVID-19 are (week 2); and what we 
need to find out about COVID-19 (week 3). 
COVID-19 Diagnostics and Testing 
FIND, LSHTM & ASLM | FutureLearn course | Starts 20 April 2020 | 3 weeks | 3 hours weekly 
study | Free 
https://www.futurelearn.com/courses/covid-19-diagnostics-and-testing 
This course is designed for professionals involved in the testing and diagnosis of COVID-19, with 
a focus on low- and middle-income settings. You will learn the latest recommendations on COVID-
19 testing, get upt0date information on the performance of tests and how best to deploy them. 
COVID-19 Critical Care: Understanding and Application 
University of Edinburgh & Royal College of Physicians of Edinburgh  | FutureLearn course | 
Starts 6 April 2020 | 5 weeks | 1 hour weekly study | Free 
https://www.futurelearn.com/courses/covid-19-critical-care-education-resource 
Designed for frontline clinical staff to learn the principles and practice of critical care to treat and 
care for critically ill patients during the COVID-19 pandemic. You will learn (1) how to apply the 
current and evolving principles of PPE in the care of COVID-19; (2) apply evidence-based 
principles of advanced organ support and monitoring to the COVID-19 critically ill patients; (3) 
apply evidence-based daily practices to care of the critically ill patient; and (4) develop a range of 
specialised self-caring practices. 
Note that this resource has been created in response to the COVID-19 emergency and does not 
correspond to the classic structure of a FutureLearn course. You do not have to follow the week 
by week approach and can select the materials most relevant to your work. 
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